Ontology highlight
ABSTRACT:
SUBMITTER: Fanikos JR
PROVIDER: S-EPMC3638402 | biostudies-other | 2013 Mar
REPOSITORIES: biostudies-other
Fanikos John R JR Atay Julie K JK Connors Jean M JM
P & T : a peer-reviewed journal for formulary management 20130301 3
Three agents have recently been approved to reduce the risk of stroke and embolism, and one agent is in phase 3 trials. These drugs cause less serious bleeding and are simpler to manage, compared with warfarin, but they are not without their risks. ...[more]